Atlas Venture Associates IX, LLC - Q3 2022 holdings

$33.7 Million is the total value of Atlas Venture Associates IX, LLC's 6 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 14.3% .

 Value Shares↓ Weighting
SKLZ  SKILLZ INC$23,368,000
-17.7%
22,909,8590.0%69.26%
+7.3%
SURF  SURFACE ONCOLOGY INC$3,063,000
-36.6%
2,945,4530.0%9.08%
-17.3%
SPRO  SPERO THERAPEUTICS INC$2,754,000
+170.3%
1,376,9680.0%8.16%
+252.6%
SYBX  SYNLOGIC INC$2,519,000
-17.4%
2,651,9630.0%7.47%
+7.8%
SNAP  SNAP INCcl a$1,475,000
-25.2%
150,1600.0%4.37%
-2.4%
NTLA  INTELLIA THERAPEUTICS INC$560,000
+8.1%
10,0000.0%1.66%
+41.0%
COGT ExitCOGENT BIOSCIENCES INC$0-466,832
-100.0%
-9.57%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTELLIA THERAPEUTICS INC28Q3 2023100.0%
SNAP INC26Q3 202311.4%
SPERO THERAPEUTICS INC24Q3 202324.0%
SYNLOGIC INC24Q2 202335.6%
SURFACE ONCOLOGY INC21Q2 202333.3%
SKILLZ INC12Q3 202387.5%
UNUM THERAPEUTICS INC11Q3 202028.2%
COGENT BIOSCIENCES INC7Q2 20229.6%
CARBON BLACK INC6Q3 20197.8%
COHERUS BIOSCIENCES INC1Q3 202318.1%

View Atlas Venture Associates IX, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04
13F-HR2021-08-11

View Atlas Venture Associates IX, LLC's complete filings history.

Compare quarters

Export Atlas Venture Associates IX, LLC's holdings